title: [Main characteristics of the care of acute myocardial infarction in Hungary between 2005-2009, based on the results of the EuroHOPE research].
abstract: BACKGROUND
  The EuroHOPE research developed the standardised methodology of the analysis of the healthcare process.
  
  
  OBJECTIVE
  The aims of the authors were to analyze the care of acute myocardial infarction in Hungary and to compare the results to those of the partner countries.
  
  
  METHODS
  The authors analyzed the application of early and late invasive interventions, medication purchase, and mortality. The results were compared to Finnish, Norwegian, Italian, Scottish and Swedish data.
  
  
  RESULTS
  By the end of the observed period, approximately half of the patients received early treatment, which is an internationally acceptable result. Purchase of statins, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers was around 90%, but the application of beta-blockers has decreased for unknown reason. The mortality rate has improved, but it was still significantly worse than that in the partnering countries. One year mortality in the early intervention group was 1.5 times higher, and in the late intervention group was 2 times higher than the second worst results.
  
  
  CONCLUSIONS
  The causal analysis concerning the professional activities, operational practices, and the role of the patients in the observed period is highly recommended. For more detailed analysis it is necessary to follow the trends and to separate the diagnoses of ST- elevation and non-ST-elevation acute myocardial infarction. Orv. Hetil., 2016, 157(41), 1626-1634.
authors.affiliation: Egészségügyi Menedzserképző Központ, Semmelweis Egyetem Budapest, Kútvölgyi út 2., 1125.
authors.forename: Éva
authors.initials: É
authors.lastname: Belicza
authors.affiliation: Egészségügyi Menedzserképző Központ, Semmelweis Egyetem Budapest, Kútvölgyi út 2., 1125.
authors.forename: Judit
authors.initials: J
authors.lastname: Lám
authors.affiliation: Honvédkórház Kardiológia Rehabilitációs Intézete Balatonfüred.|Orvosi Rehabilitációs és Fizikális Medicina Tanszék, Szegedi Tudományegyetem, Általános Orvostudományi Kar Szeged.
authors.forename: István
authors.initials: I
authors.lastname: Kósa
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D019985:Benchmarking / Q000379:methods*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D007558:Italy / Q000453:epidemiology; D008297:Male; D009203:Myocardial Infarction / Q000401:mortality* / Q000628:therapy*; D062645:Percutaneous Coronary Intervention / Q000706:statistics & numerical data; D011379:Prognosis; D012042:Registries; D012307:Risk Factors; D012537:Scandinavian and Nordic Countries / Q000453:epidemiology; D013997:Time Factors
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors
keywords: gyógyszeralkalmazás; halálozás; medication; mortality; myocardial infarction; myocardialis infarctus